Oramed Pharmaceuticals
ORMP
#9127
Rank
S$0.14 B
Marketcap
S$3.66
Share price
1.42%
Change (1 day)
10.87%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): S$74.05 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are S$2 Million. In 2024 the company made an earning of -S$19.37 Million a decrease over its 2023 earnings that were of S$9.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$74.05 M-482.33%
2024 -S$19.37 Million-311.47%
2023 S$9.15 M-119.45%
2022 -S$47.09 Million39.17%
2021 -S$33.84 Million73.93%
2020 -S$19.46 Million18.53%
2019 -S$16.42 Million-16.62%
2018 -S$19.69 Million38.32%
2017 -S$14.23 Million12.51%
2016 -S$12.65 Million25.01%
2015 -S$10.12 Million18.18%
2014 -S$8.57 Million39.72%
2013 -S$6.13 Million46.4%
2012 -S$4.19 Million128.32%
2011 -S$1.84 Million-51.47%
2010 -S$3.78 Million35.21%
2009 -S$2.8 Million
2007 -S$4.4 Million607.04%
2006 -S$0.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-S$0.67 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$26.79 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$11.69 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-S$35.43 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-S$88.16 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA